Merck secures exclusive global license for opevesostat from Orion Corporation

Pallavi Madhiraju- July 7, 2024 0

Merck (NYSE: MRK), also known as MSD outside the United States and Canada, has enhanced its strategic position in the oncology market by securing an ... Read More

Zynext Ventures invests in Promaxo’s innovative MRI and robotic technologies

Pallavi Madhiraju- June 19, 2024 0

Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Promaxo Inc., a leading developer of portable low-field ... Read More

Telix Pharmaceuticals advances prostate cancer treatment with successful TLX592 study

Pallavi Madhiraju- May 21, 2024 0

Telix Pharmaceuticals Limited (ASX: TLX) has announced the successful completion of the CUPID Phase I dose escalation study of TLX592, marking a significant advancement in ... Read More